Literature DB >> 12654412

Lifestyle factors and the risk of varicose veins: Edinburgh Vein Study.

Amanda J Lee1, Christine J Evans, Paul L Allan, C Vaughan Ruckley, F Gerald R Fowkes.   

Abstract

The objective of this study was to determine the inter-relationships between a range of lifestyle factors and risk of varicose veins to identify which factors may be implicated in the etiology. An age-stratified random sample of 1566 subjects (699 men and 867 women) aged 18 to 64 years was selected from 12 general practices throughout Edinburgh. A detailed self-administered questionnaire was completed, and a comprehensive physical examination determined the presence and severity of varicose veins. The slightly higher age-adjusted prevalence of varicose veins in men than in women (39.7% versus 32.2%) was not explained by adjustment for an extensive range of lifestyle risk factors (male odds ratio [OR] 2.11, 95% confidence interval [CI] 1.51-2.96). In both sexes, increasing height showed a significant relationship with varicose veins (male OR 1.50, 95% CI 1.18-1.93 and female OR 1.26, 95% CI 1.01-1.58). Among women, body mass index was associated with an increased risk of varicose veins (OR 1.26, 95% CI 1.02-1.54). The current study casts doubt as to whether varicose veins occur predominantly in women. In addition, no consistent relationship with any lifestyle factor was shown. Self-reported evidence suggested a familial susceptibility, thereby warranting future genetic studies.

Entities:  

Mesh:

Year:  2003        PMID: 12654412     DOI: 10.1016/s0895-4356(02)00518-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  30 in total

Review 1.  Varicose veins and their management.

Authors:  Bruce Campbell
Journal:  BMJ       Date:  2006-08-05

2.  How should a candidate assess varicose veins in the MRCS clinical examination? A vascular viewpoint.

Authors:  N Bhasin; D J A Scott
Journal:  Ann R Coll Surg Engl       Date:  2006-05       Impact factor: 1.891

3.  Clinical and Genetic Determinants of Varicose Veins.

Authors:  Eri Fukaya; Alyssa M Flores; Daniel Lindholm; Stefan Gustafsson; Daniela Zanetti; Erik Ingelsson; Nicholas J Leeper
Journal:  Circulation       Date:  2018-12-18       Impact factor: 29.690

4.  Standing Posture at Work Does Not Increase the Risk of Varicose Veins among Health Care Providers in Taiwan.

Authors:  Hsin-Kai Huang; Shih-Feng Weng; Shih-Bin Su; Jhi-Joung Wang; How-Ran Guo; Chien-Chin Hsu; Chien-Cheng Huang; Hung-Jung Lin
Journal:  Med Princ Pract       Date:  2017-02-28       Impact factor: 1.927

Review 5.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 6.  Review of epidemiologic studies on occupational factors and lower extremity musculoskeletal and vascular disorders and symptoms.

Authors:  Jennifer C D'Souza; Alfred Franzblau; Robert A Werner
Journal:  J Occup Rehabil       Date:  2005-06

Review 7.  CHIVA method for the treatment of chronic venous insufficiency.

Authors:  Sergi Bellmunt-Montoya; Jose Maria Escribano; Jaume Dilme; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2015-06-29

8.  Distal lower-extremity pain and work postures in the Quebec population.

Authors:  Karen Messing; France Tissot; Susan Stock
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

9.  [Evaluation of a standardized questionnaire to screen for venous diseases].

Authors:  M Stücker; S Puyn; E Rabe; P Altmeyer; S Reich-Schupke
Journal:  Hautarzt       Date:  2010-03       Impact factor: 0.751

10.  A genetic risk score comprising known venous thromboembolism loci is associated with chronic venous disease in a multi-ethnic cohort.

Authors:  Christina L Wassel; Laura J Rasmussen-Torvik; Peter W Callas; Julie O Denenberg; J Peter Durda; Alexander P Reiner; Nicholas L Smith; Matthew A Allison; Frits R Rosendaal; Michael H Criqui; Mary Cushman
Journal:  Thromb Res       Date:  2015-09-26       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.